<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>The Ethics of AI</title>
    <link rel="stylesheet" href="style.css">
</head>
<body>
    <header>
        <h1>Rishi Rajendra Gandhi</h1>
        <p>Astrobiologist • Marine Microbiologist • Ex-iGEMer • Analog Astronaut</p>
    </header>

    <nav>
        <a href="index.html">Home</a>
        <a href="presentation.html">Presentations</a>
        <a href="Project.html">Projects</a>
        <a href="Publication.html">Publications</a>
        <a href="Blog.html" class="active">Blog</a>
        <a href="contact.html">Contact</a>
    </nav>

    <main>
        <section class="blog-post">
            <div class="blog-image">Image Placeholder</div>
            <h2 class="blog-title">CRISPR & Gene Editing: Advances in Gene Therapy, Synthetic Biology, and Disease Resistance</h2>
            <h3 class="blog-title"><p>The CRISPR Revolution</p><br></h3>

<p style="text-align: justify;">CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has transformed the field of genetic engineering. Originally discovered as a bacterial immune system, CRISPR-Cas9 allows precise, efficient, and affordable gene editing. Scientists can now target and modify specific DNA sequences, opening doors to revolutionary applications in medicine, agriculture, and synthetic biology.</p><br>

<h3 class="blog-title"><p>Gene Therapy: Treating Genetic Disorders</p><br></h3>

<p style="text-align: justify;">One of CRISPR’s most promising applications is in gene therapy, where defective genes causing diseases like sickle cell anemia, cystic fibrosis, and muscular dystrophy can be repaired.</p><br>

<p style="text-align: justify;">In 2023, the first CRISPR-based therapy for sickle cell disease, Casgevy, was approved, marking a milestone in personalized medicine.Scientists are exploring CRISPR for treating cancer, HIV, and neurological disorders like Alzheimer’s and Parkinson’s.The potential for in vivo (inside the body) editing is being tested to correct genetic mutations directly within affected tissues.</p><br>

<h3 class="blog-title"><p>Synthetic Biology: Designing Life</p><br></h3>

<p>CRISPR is also shaping synthetic biology, where genes are engineered to create new biological functions:</p><br>

<p>Biofuel production: Scientists modify microbes to enhance their ability to break down biomass and produce clean energy.</p>

<p>Biopharmaceuticals: CRISPR is used to engineer bacteria and yeast to produce drugs, including insulin and antibiotics.</p>

<p>Environmental solutions: Researchers are designing microbes that can consume plastic waste or absorb atmospheric CO₂.</p><br>

<h3 class="blog-title"><p>Building Disease Resistance in Humans and Agriculture</p><br></h3>

<p>Another major breakthrough is in disease resistance:</p><br>

<p>Human immunity: Scientists are exploring CRISPR to enhance human resistance to viruses like HIV and SARS-CoV-2.</p>

<p>Crops and livestock: Genetically edited plants resist pests without pesticides, while livestock can be bred to resist diseases, reducing antibiotic dependence.</p>

<p>Malaria eradication: CRISPR-modified mosquitoes are being tested to reduce populations of malaria-carrying species.</p><br>

<h3 class="blog-title"><p>Eugenics and the Ethical Dilemma</p><br></h3>

<p style="text-align: justify;">While CRISPR offers groundbreaking medical benefits, it also raises ethical concerns, particularly regarding eugenics—the idea of selectively modifying genes to create “better” humans.</p>

<p style="text-align: justify;">-Germline Editing: Unlike somatic gene therapy (which affects only the individual), germline edits (in embryos) are inherited by future generations. This raises the risk of unintended consequences and social inequality.</p>

<p style="text-align: justify;">-Designer Babies: Some fear CRISPR could be misused to enhance intelligence, athleticism, or appearance, creating a divide between genetically modified and non-modified individuals.</p>

<p style="text-align: justify;">-Global Regulation: Countries are debating laws around gene editing. While China has controversially experimented with human embryo editing, most nations remain cautious.</p><br>

<h3 class="blog-title"><p>The Future of CRISPR</p><br></h3>

<p style="text-align: justify;">Despite ethical concerns, CRISPR is pushing science forward. Efforts are underway to refine the technology, minimize risks, and ensure equitable access. Scientists envision a future where genetic diseases are eradicated, synthetic biology revolutionizes industries, and gene editing is applied responsibly.</p><br>

<h3 class="blog-title"><p>The question remains: Where should we draw the line between healing and enhancing humanity?</p></h3>

</p>
        </section>
    </main>

    <footer>
        <p>© 2025 Rishi Rajendra Gandhi. All rights reserved.</p>
    </footer>
</body>
</html>
